CAS 56302-13-7: Satranidazole

Satranidazole is an anti-bacterial. It is used to treat periodontitis.

Satranidazole is an antimicrobial agent that falls under the category of synthetic nitroimidazoles. It is derived from chemical synthesis and is designed to combat infections caused by specific organisms. The mode of action involves the reduction of the nitro group within the organism, creating reactive intermediates that disrupt DNA synthesis and lead to cell death. This mode of action is notably effective against protozoal infections and anaerobic bacterial infections. Satranidazole's applications primarily include the treatment of parasitic diseases such as amebiasis and giardiasis, and it is particularly effective in addressing anaerobic bacterial infections often encountered in clinical settings. Due to its targeted mechanism, Satranidazole is valuable in treating conditions where conventional antibiotics might be less effective. Its use in therapeutics highlights the importance of precise molecular intervention in the realm of infectious diseases. Researchers and practitioners utilize Satranidazole for its specific activity and efficacy in treating difficult-to-manage infections.